ProShares Ultra NASDAQ Biotechnology
BIB
BIB
25 hedge funds and large institutions have $5.97M invested in ProShares Ultra NASDAQ Biotechnology in 2019 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 7 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
57% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 7
82% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 11
Holders
25
Holding in Top 10
–
Calls
$3.2M
Puts
$4.3M
Top Sellers
| 1 | -$2.53M | |
| 2 | -$1.59M | |
| 3 | -$1.02M | |
| 4 |
BRC
Bell Rock Capital
Rehoboth Beach,
Delaware
|
-$678K |
| 5 |
Koshinski Asset Management
Decatur,
Illinois
|
-$263K |